% alzhub.org library filter % Source: https://alzhub.org/research?author=Hansson+O&year=2021 % 12 entries, in the order the page lists them. Built from alzhub.org's own records. % 0 entries have no readable author in the source record and carry no author field. @article{pereira2021-34077494, author = {Pereira, J. B. and Janelidze, S. and Stomrud, E. and Palmqvist, S. and van Westen, D. and Dage, J. L. and Mattsson-Carlgren, N. and Hansson, O.}, title = {{Plasma markers predict changes in amyloid, tau, atrophy and cognition in non-demented subjects}}, journal = {Brain : a journal of neurology}, year = {2021}, doi = {10.1093/brain/awab163}, pmid = {34077494}, url = {https://doi.org/10.1093/brain/awab163} } @article{cicognola2021-33773595, author = {Cicognola, C. and Janelidze, S. and Hertze, J. and Zetterberg, H. and Blennow, K. and Mattsson-Carlgren, N. and Hansson, O.}, title = {{Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment}}, journal = {Alzheimer's research \& therapy}, year = {2021}, doi = {10.1186/s13195-021-00804-9}, pmid = {33773595}, url = {https://doi.org/10.1186/s13195-021-00804-9} } @article{cicognola2021-d7e9adeb, author = {Cicognola, C. and Janelidze, S. and Hertze, J. and Zetterberg, H. and Blennow, K. and Mattsson-Carlgren, N. and Hansson, O.}, title = {{Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment}}, journal = {Alzheimer's Research \& Therapy}, year = {2021}, doi = {10.1186/s13195-021-00804-9}, pmid = {33773595}, url = {https://doi.org/10.1186/s13195-021-00804-9} } @article{bischof2021-33590274, author = {Bischof, G. N. and Dodich, A. and Boccardi, M. and van Eimeren, T. and Festari, C. and Barthel, H. and Hansson, O. and Nordberg, A. and others}, title = {{Clinical validity of second-generation tau PET tracers as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework}}, journal = {European journal of nuclear medicine and molecular imaging}, year = {2021}, doi = {10.1007/s00259-020-05156-4}, pmid = {33590274}, url = {https://doi.org/10.1007/s00259-020-05156-4} } @article{cullen2022-34937781, author = {Cullen, N. and Janelidze, S. and Palmqvist, S. and Stomrud, E. and Mattsson-Carlgren, N. and Hansson, O. and {Alzheimer’s Disease Neuroimaging Initiative}}, title = {{Association of CSF Aβ38 Levels With Risk of Alzheimer Disease-Related Decline}}, journal = {Neurology}, year = {2022}, doi = {10.1212/wnl.0000000000013228}, pmid = {34937781}, url = {https://doi.org/10.1212/wnl.0000000000013228} } @article{provost2021-33398408, author = {Provost, K. and Iaccarino, L. and Soleimani-Meigooni, D. N. and Baker, S. and Edwards, L. and Eichenlaub, U. and Hansson, O. and Jagust, W. and others}, title = {{Comparing ATN-T designation by tau PET visual reads, tau PET quantification, and CSF PTau181 across three cohorts}}, journal = {European journal of nuclear medicine and molecular imaging}, year = {2021}, doi = {10.1007/s00259-020-05152-8}, pmid = {33398408}, url = {https://doi.org/10.1007/s00259-020-05152-8} } @article{verberk2022-34845818, author = {Verberk, I. M. W. and Misdorp, E. O. and Koelewijn, J. and Ball, A. J. and Blennow, K. and Dage, J. L. and Fandos, N. and Hansson, O. and others}, title = {{Characterization of pre-analytical sample handling effects on a panel of Alzheimer's disease-related blood-based biomarkers: Results from the Standardization of Alzheimer's Blood Biomarkers (SABB) working group}}, journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association}, year = {2022}, doi = {10.1002/alz.12510}, pmid = {34845818}, url = {https://doi.org/10.1002/alz.12510} } @article{teunissen2022-34838239, author = {Teunissen, C. E. and Verberk, I. M. W. and Thijssen, E. H. and Vermunt, L. and Hansson, O. and Zetterberg, H. and van der Flier, W. M. and Mielke, M. M. and others}, title = {{Blood-based biomarkers for Alzheimer's disease: towards clinical implementation}}, journal = {The Lancet. Neurology}, year = {2022}, doi = {10.1016/s1474-4422(21)00361-6}, pmid = {34838239}, url = {https://doi.org/10.1016/s1474-4422(21)00361-6} } @article{leuzy2022-34859598, author = {Leuzy, A. and Mattsson-Carlgren, N. and Palmqvist, S. and Janelidze, S. and Dage, J. L. and Hansson, O.}, title = {{Blood-based biomarkers for Alzheimer's disease}}, journal = {EMBO molecular medicine}, year = {2022}, doi = {10.15252/emmm.202114408}, pmid = {34859598}, url = {https://doi.org/10.15252/emmm.202114408} } @article{ossenkoppele2021-33984177, author = {Ossenkoppele, R. and Hansson, O.}, title = {{Towards clinical application of tau PET tracers for diagnosing dementia due to Alzheimer's disease}}, journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association}, year = {2021}, doi = {10.1002/alz.12356}, pmid = {33984177}, url = {https://doi.org/10.1002/alz.12356} } @article{wolters2021-33547556, author = {Wolters, E. E. and Dodich, A. and Boccardi, M. and Corre, J. and Drzezga, A. and Hansson, O. and Nordberg, A. and Frisoni, G. B. and others}, title = {{Clinical validity of increased cortical uptake of [18F]flortaucipir on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase biomarker development framework}}, journal = {European journal of nuclear medicine and molecular imaging}, year = {2021}, doi = {10.1007/s00259-020-05118-w}, pmid = {33547556}, url = {https://doi.org/10.1007/s00259-020-05118-w} } @article{leuzy2021-33470669, author = {Leuzy, A. and Cullen, N. C. and Mattsson-Carlgren, N. and Hansson, O.}, title = {{Current advances in plasma and cerebrospinal fluid biomarkers in Alzheimer's disease}}, journal = {Current opinion in neurology}, year = {2021}, doi = {10.1097/wco.0000000000000904}, pmid = {33470669}, url = {https://doi.org/10.1097/wco.0000000000000904} }